Search Results

You searched for : Etanercept

	Lupin and Mylan launch Nepexto, biosimilar etanercept in Germany The approval of Nepexto by the European Medicines Agency (EMA) underlines the scientific success of Lupinâ€™s biosimilar programs... Aug 26
	Sun Pharma announces Japan MHLW approval of ILUMYA ILUMYA is one of the key specialty products of Sun Pharma... Jun 29
	Mylan and Lupin Announce Positive CHMP Opinion for NepextoÂ®, Biosimilar Etanercept The CHMP positive opinion will now be considered by the European Commission (EC). Once approved the EC will grant a centralized marketing authorization for member ... Mar 28
	Mundipharma Enters Partnership With Samsung Bioepis to Expand Biosimilars Into Hong Kong and Taiwan Through the partnership, Mundipharma will be the exclusive commercialization partner, while Samsung Bioepis will remain the Marketing Authorisation Holder (MAH),... Jan 20
	Lupin posts 123 crores loss,more product launch on cards ! Lupin posts 123 crore loss for Q2,2019... Nov 08
	Samsung Bioepis Continues Global Expansion, Enters Brazilian Biopharmaceutical Market with BRENZYSâ„¢ (etanercept) Samsung Bioepisâ€™ BRENZYSâ„¢ (etanercept) becomes available in Brazil through Brazilâ€™s public health system, Sistema Ãšnico de SaÃºde (SUS) Established seven years ago, Samsung ... Sep 11
6 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

Lupin and Mylan launch Nepexto, biosimilar etanercept in Germany

Sun Pharma announces Japan MHLW approval of ILUMYA

Mylan and Lupin Announce Positive CHMP Opinion for NepextoÂ®, Biosimilar Etanercept

Mundipharma Enters Partnership With Samsung Bioepis to Expand Biosimilars Into Hong Kong and Taiwan

Lupin posts 123 crores loss,more product launch on cards !

Samsung Bioepis Continues Global Expansion, Enters Brazilian Biopharmaceutical Market with BRENZYSâ„¢ (etanercept)

Trending Now